When assessing the potential biological importance of the analyzed variants, SEMA3C stood out, jointly due to its large number of NCCMs and the existing literature suggesting that overexpression of SEMA3C is linked to poor prognosis in several cancer types including prostate cancer [55] and GBM [56]. This evidence concerns the gene SEMA3C and glioblastoma.